Clinical trial

Circulating microRNA 21 Expression Level Before and After Neoadjuvant Systemic Therapy in Breast Carcinoma

NCT05151224

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2021-12-01

PhaseN/A

Study timeline

Study start (estimated)2021-12-01Date precision: month

Registry last updated2021-12-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Carcinomaunresolved

Interventions

microRNA 21DIAGNOSTIC_TEST

Sponsors & collaborators

Ain Shams Universitylead sponsor

Mapped research locations

CairoEgypt1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05151224 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.